Drugs for acute severe UC to be assessed by UK's NIHR HTA

The UK's National Institute for Health Research Health Technology Assessment program has funded a L1.6 million ($2.9 million) clinical trial to compare two powerful drugs for people with steroid resistant acute severe ulcerative colitis. UC affects around 150,000 people in the UK and is a major burden on both patients and National Health Service resources, as it often leads to severe morbidity, grossly impaired quality of life, frequent and long in-patients stays, as well as emergency colectomy.